Spirit Health has announced its new continuous glucose monitor (CGM), CareSens Air, will be available on the Drug Tariff from February 1 this year.
The advanced, user-friendly system is set to revolutionise diabetes management with its affordability, simplicity and cutting-edge features – offering more choice for people with diabetes.
CareSens Air is a 15-day wear device that delivers glucose readings directly to a user’s smartphone, enabling real-time monitoring and empowering users to take control of their -health. With a slim, lightweight design and all-in-one applicator, the system ensures a seamless experience for individuals living with diabetes.
Chris Barker, Chief Executive of Spirit Health, said: “We’re thrilled to bring CareSens Air to the Drug Tariff this February. This innovative device bridges critical gaps in diabetes care by offering a reliable, user-friendly tool that enhances patient outcomes while being mindful of healthcare budgets helping us make healthcare simple and more accessible for all.”
According to prescription data, the UK CGM market is currently dominated by Abbott, which accounts for 95 per cent of sales, with Dexcom holding a four per cent share. CareSens Air enables an additional choice for these patients in the future.
Dedicated to making healthcare simple, accessible, and affordable, the launch of CareSens Air aligns with Spirit Health’s determination to support patients and healthcare providers with impactful, cost-effective solutions.
The CareSens Air app elevates diabetes management with features including real-time trend tracking, personalised alerts for glucose levels, and lifelong integration to help users understand how daily activities influence their health. The app’s remote monitoring capability also allows healthcare professionals and carers to access live glucose data, detailed reports, and actionable insights, supporting proactive patient care.
Spirit Health’s comprehensive offerings span medicine optimisation, digital health technology, GP practices, education services and online pharmacy, enabling them to support individuals and the NHS holistically. Through initiatives such as Clinitouch for managing long-term conditions and EMPOWER, the award-winning diabetes education programme, Spirit Health bridges gaps in care and drives meaningful, lasting change.
Spirit Health works alongside the NHS and global partners to deliver solutions tailored to real-world needs, backed by evidence and award-winning expertise. Guided by a holistic approach and a culture of innovation, the Spirit Health team of clinical and non-clinical professionals ensures every service is centred around people living with diabetes and their healthcare partners.
Recognised by ‘Best Companies to work for’ in multiple categories since 2021, Spirit Health remains dedicated to building long-term relationships and transforming healthcare for the better.
For more information on the CareSens Air, please visit www.spirit-health.com
Customer Reviews
Thanks for submitting your comment!